Literature DB >> 12697918

Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia.

N Lubis1, D Baylis, A Short, J Stebbing, A Teague, S Portsmouth, M Bower, M Nelson, B Gazzard.   

Abstract

Pneumocystis carinii pneumonia (PCP) remains a serious opportunistic infection in HIV infected individuals. Seasonal changes in climate are associated with changes within individual susceptibility to infection. The possibility of monthly variability in the incidence of PCP was therefore examined by means of a cohort study of a database of 8640 HIV infected individuals attending the Chelsea and Westminster Hospital. There were 792 cases of PCP diagnosed since 1985. A marked decline was observed in the incidence of PCP in mid-1992 coincident with the introduction of PCP prophylaxis. There was a further decline in 1996 after the introduction of highly active antiretroviral therapy. Despite no significant monthly variation in the mean attendance to clinic and CD4 count, both new and all cases of PCP were higher in January than in other months (15.9% and 14.5% of all cases, respectively). A correlation with low rainfall in January and new cases of PCP was observed. These data are consistent with an influence of climatic conditions on the presentation of PCP. The diagnosis of PCP is more common in winter months suggesting that this is a transmissible infection.

Entities:  

Mesh:

Year:  2003        PMID: 12697918      PMCID: PMC1742624          DOI: 10.1136/pmj.79.929.164

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  16 in total

Review 1.  An explanation for the seasonality of acute upper respiratory tract viral infections.

Authors:  R Eccles
Journal:  Acta Otolaryngol       Date:  2002-03       Impact factor: 1.494

2.  Seasonal variation in presentation of Pneumocystis carinii pneumonia.

Authors:  R F Miller; A D Grant; N M Foley
Journal:  Lancet       Date:  1992-03-21       Impact factor: 79.321

3.  Seasonal incidence of Pneumocystis carinii pneumonia.

Authors:  P Vanhems; B Hirschel; A Morabia
Journal:  Lancet       Date:  1992-05-09       Impact factor: 79.321

4.  Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.

Authors:  A Mocroft; C A Sabin; M Youle; S Madge; M Tyrer; H Devereux; J Deayton; A Dykhoff; M C Lipman; A N Phillips; M A Johnson
Journal:  J Acquir Immune Defic Syndr       Date:  1999-08-15       Impact factor: 3.731

5.  Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.

Authors:  J Helweg-Larsen; T L Benfield; J Eugen-Olsen; J D Lundgren; B Lundgren
Journal:  Lancet       Date:  1999-10-16       Impact factor: 79.321

Review 6.  Pneumocystis carinii.

Authors:  Ann E Wakefield
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

7.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

8.  Seasonal dynamics of Pneumocystis carinii in the field vole, Microtus agrestis, and in the common shrew, Sorex araneus, in Finland.

Authors:  J Laakkonen; H Henttonen; J Niemimaa; T Soveri
Journal:  Parasitology       Date:  1999-01       Impact factor: 3.234

9.  Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis.

Authors:  S P Keely; J R Stringer; R P Baughman; M J Linke; P D Walzer; A G Smulian
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

Authors:  J Phair; A Muñoz; R Detels; R Kaslow; C Rinaldo; A Saah
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

View more
  11 in total

1.  Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.

Authors:  Kpandja Djawe; Kieran R Daly; Sergio L Vargas; M Elena Santolaya; Carolina A Ponce; Rebeca Bustamante; Judith Koch; Linda Levin; Peter D Walzer
Journal:  Int J Infect Dis       Date:  2010-12       Impact factor: 3.623

2.  Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality.

Authors:  J Stebbing; M Bower; S Mandalia; M Nelson; B Gazzard
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 3.  The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities.

Authors:  Peter D Walzer
Journal:  J Eukaryot Microbiol       Date:  2013-09-03       Impact factor: 3.346

4.  Seasonal variation in undiagnosed HIV infection on the general medicine and trauma services of two urban hospitals.

Authors:  Kathleen A Brady; Sheila Berry; Rajan Gupta; Mark Weiner; Barbara J Turner
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

5.  Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus.

Authors:  Ratchaya Lertnawapan; Kitti Totemchokchyakarn; Kanokrat Nantiruj; Suchela Janwityanujit
Journal:  Rheumatol Int       Date:  2008-09-25       Impact factor: 2.631

6.  Environmental risk factors for Pneumocystis pneumonia hospitalizations in HIV patients.

Authors:  Kpandja Djawe; Linda Levin; Alexandra Swartzman; Serena Fong; Brenna Roth; Anuradha Subramanian; Katherine Grieco; Leah Jarlsberg; Robert F Miller; Laurence Huang; Peter D Walzer
Journal:  Clin Infect Dis       Date:  2012-10-05       Impact factor: 9.079

7.  Characterizing Pneumocystis in the lungs of bats: understanding Pneumocystis evolution and the spread of Pneumocystis organisms in mammal populations.

Authors:  Haroon Akbar; Claire Pinçon; Cecile-Marie Aliouat-Denis; Sandra Derouiche; Maria-Lucia Taylor; Muriel Pottier; Laura-Helena Carreto-Binaghi; Antonio E González-González; Aurore Courpon; Véronique Barriel; Jacques Guillot; Magali Chabé; Roberto O Suarez-Alvarez; El Moukhtar Aliouat; Eduardo Dei-Cas; Christine Demanche
Journal:  Appl Environ Microbiol       Date:  2012-09-21       Impact factor: 4.792

Review 8.  Pneumocystis jirovecii colonization in chronic pulmonary disease.

Authors:  S Gutiérrez; N Respaldiza; E Campano; M T Martínez-Risquez; E J Calderón; C De La Horra
Journal:  Parasite       Date:  2011-05       Impact factor: 3.000

9.  Epidemiological characteristics of pulmonary pneumocystosis and concurrent infections in pigs in Jeju Island, Korea.

Authors:  Ki-Seung Kim; Ji-Youl Jung; Jae-Hoon Kim; Sang-Chul Kang; Eui-Kyung Hwang; Bong-Kyun Park; Dae-Yong Kim; Jae-Hoon Kim
Journal:  J Vet Sci       Date:  2011-03       Impact factor: 1.672

Review 10.  Pneumocystis Pneumonia in Solid-Organ Transplant Recipients.

Authors:  Xavier Iriart; Marine Le Bouar; Nassim Kamar; Antoine Berry
Journal:  J Fungi (Basel)       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.